Evidence map›Paper›PMID 15703078›Full record

ArticleBMC biotechnology2005

Functional complementation of RNA interference mutants in trypanosomes.

Filippo Rusconi, Mickaël Durand-Dubief, Philippe Bastin

Open access · goldAbstract read
In one paragraph

Article in BMC biotechnology, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.1field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Article
  3. Deep mutational scanning of the RNase III-like domain inFrontiers in cellular and infection microbiology · 2024
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Flagellar motility of Trypanosoma cruzi epimastigotes.Journal of biomedicine & biotechnology · 2012
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Silence of the transcripts: RNA interference in medicine.Journal of molecular medicine (Berlin, Germany) · 2005
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 1 country.

Filippo RusconiUMR5153 CNRS, USM0503 MNHN, U565 INSERM-57, rue Cuvier, P.B 26 - F-75231, Paris Cedex 05, France. rusconi@mnhn.fr
Mickaël Durand-Dubief
Philippe Bastin
Centre National de la Recherche Scientifique · FRInserm · FRStructure et Instabilité des Génomes · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIn many eukaryotic cells, double-stranded RNA (dsRNA) triggers RNA interference (RNAi), the specific degradation of RNA of homologous sequence. RNAi is now a major tool for reverse-genetics projects, including large-scale high-throughput screens. Recent reports have questioned the specificity of RNAi, raising problems in interpretation of RNAi-based experiments.

resultsUsing the protozoan Trypanosoma brucei as a model, we designed a functional complementation assay to ascertain that phenotypic effect(s) observed upon RNAi were due to specific silencing of the targeted gene. This was applied to a cytoskeletal gene encoding the paraflagellar rod protein 2 (TbPFR2), whose product is essential for flagellar motility. We demonstrate the complementation of TbPFR2, silenced via dsRNA targeting its UTRs, through the expression of a tagged RNAi-resistant TbPFR2 encoding a protein that could be immunolocalized in the flagellum. Next, we performed a functional complementation of TbPFR2, silenced via dsRNA targeting its coding sequence, through heterologous expression of the TbPFR2 orthologue gene from Trypanosoma cruzi: the flagellum regained its motility.

conclusionsThis work shows that functional complementation experiments can be readily performed in order to ascertain that phenotypic effects observed upon RNAi experiments are indeed due to the specific silencing of the targetted gene. Further, the results described here are of particular interest when reverse genetics studies cannot be easily achieved in organisms not amenable to RNAi. In addition, our strategy should constitute a firm basis to elaborate functional-dissection studies of genes from other organisms.

Indexed as

Genetic Complementation TestMutationRNA InterferenceAnimalsCell LineCytoskeletonFlagellaGene ExpressionGene Expression RegulationGene SilencingGenes, ProtozoanGene TargetingModels, GeneticMovementPhenotypePlasmidsProtozoan ProteinsRNA, Double-Stranded

Identifiers

PMID15703078
PMCPMC549545
OpenAlexW1832628174

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.